My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Thalidomide BMS



Bristol-Myers Squibb Pharmaceuticals ucEU/1/08/443/1

Main Information

Trade NameThalidomide BMS
Active SubstancesThalidomide
Dosage FormCapsule, hard
Licence HolderBristol-Myers Squibb Pharmaceuticals uc
Licence NumberEU/1/08/443/1

Group Information

ATC CodeL04AX Other immunosuppressants
L04AX02 thalidomide

Status

License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal roduct subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print